LACA mice can provide advantages against C57BL/6 when studying genes such as Zic1 or Olig1 or their associated pathways, which can be explored clinically as alternative strategies for the treatment of obesity and associated co-morbidities. This evidence concerns the gene OLIG1 and obesity disorder.